Researchers at the University of South Australia have developed a microneedle patch with antibacterial properties to make vaccinations safer than traditional needles or other microneedles.
News & Features
A new technology can diagnose a suspicious lesion in breast tissue in a third of a second, Dune Medical Devices reported.
The ECRI Institute identified these issues as the biggest patient safety concerns in 2019. Can medtech help tackle them?
The company said it is preparing a written response to FDA and has taken steps to remediate the observations made during an FDA inspection last year.
As the Irvine, CA-based company strengthens its mitral valve portfolio, it also faces a lawsuit from Abbott Laboratories over the Pascal system.
The agency released a letter to healthcare providers pointing out the risks and said it would hold a public advisory committee meeting.
Think your startup has what it takes to go head to head with other young companies in medtech? Find out by entering our annual tournament.
Ablative Solutions revealed data from the Peregrine Post-Market Study during the 2019 Cardiovascular Research Technologies meeting in Washington D.C. recently.
The new diagnostic assay format could provide a means of performing low-cost tests for particular strains of flu at the point of care, but there are challenges to address.
An investigative report claims FDA is hiding millions of adverse event reports from the public under the guise of an alternative summary reporting program.
University of Gothenburg researchers were able to use artificial intelligence and conventional statistical methods to identify the most important indicators of elevated risk for cardiovascular disease and death.
The company said it will sell its health information systems business unit to Philips. The deal is expected to close later this year.